A personal tragedy led Andreas Melhede down a path that could forever change how science operates. The Elata Biosciences founder watched someone close to him face severe depression and anxiety in a foreign country, confronting language barriers and medical uncertainty.
Despite trying every medication, supplement, and lifestyle change available, nothing made a significant difference for that person. That experience exposed the reality that psychiatric treatment remains guesswork, with failure rates exceeding 70% for some conditions.
